Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases

PURPOSE: To examine the evidence on the cost-effectiveness of implementing pharmacogenomics (PGx) in cardiovascular disease (CVD) care. METHODS: We conducted a systematic review using multiple databases from inception to 2018. The titles and abstracts of cost-effectiveness studies on PGx-guided trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ye, Swanson, Kristi M., Rojas, Ricardo L., Wang, Zhen, St. Sauver, Jennifer L., Visscher, Sue L., Prokop, Larry J., Bielinski, Suzette J., Wang, Liewei, Weinshilboum, Richard, Borah, Bijan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2019
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056639/
https://www.ncbi.nlm.nih.gov/pubmed/31591509
http://dx.doi.org/10.1038/s41436-019-0667-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056639/
https://www.ncbi.nlm.nih.gov/pubmed/31591509
http://dx.doi.org/10.1038/s41436-019-0667-y

Ejemplares similares